# RANOLAZINE
> **ANDA211361** · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2025-04-15
## Drug
- **FDA Application Number:** ANDA211361
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANOLAZINE
- **Generic name:** Ranolazine
- **Active ingredients:** RANOLAZINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JUBILANT GENERICS
- **First approval:** 2025-04-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211361)
---
*AI Analytics · CC0 1.0*